American Journal of Pathology 2007, 170:1445–1453.https://www.selleckchem.com/products/tpca-1.html PubMedCrossRef 2. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, Hahn WC, SAHA supplier Ligon KL, Louis DN, Brennan C, Chin L, DePinho RA, Cavenee WK: Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes and Development 2007, 21:2683–2710.PubMedCrossRef 3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of
the central nervous system. Acta Neuropathologica 2007, 114:97–109.PubMedCrossRef 4. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ: Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer Journal for Clinicians 2010, 60:166–193.CrossRef 5. Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S: An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 2001, 61:5544–51.PubMed 6. Xiao J, Chen HS: Biological functions of melanoma-associated antigens. World J Gastroenterol 2004, 10:1849–53.PubMed 7. De Plaen E, Arden MLN4924 concentration K, Traversari C, Gaforio JJ, Szikora JP, De Smet C, Brasseur F, van der Bruggen P, Lethe B, Lurquin C: Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994, 40:360–9.PubMedCrossRef 8. Marchand M, Van Baren N, Weynants P: Tumor regressions observed in patients with metastatic treated with
antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999, 80:219–30.PubMedCrossRef 9. Kruit WH, Van Ojik HH, Brichard VG: Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma. Int J Cancer 2005, 117:596–4.PubMedCrossRef 10. Van Baren N, Bonnet MC, Dreno B: Tumoral and immunologic response after vaccination of melanoma GNA12 patients
with an ALVAC virus encoding MAGE antigens recognized by T cells. J Clin Oncol 2005, 23:9008–21.PubMedCrossRef 11. Peikert T, Specks U, Farver C, Erzurum SC, Comhair SA: Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Cancer Res 2006, 66:4693–700.PubMedCrossRef 12. Shen WG, Xue QY, Zhu J: Inhibition of adenovirus-mediated human MAGE-D1 on angiogenesis in vitro and in vivo. Mol Cell Biochem 2007, 300:89–99.PubMedCrossRef 13. Krause KH, Michalak M: Calreticulin Cell. 1997, 88:439–443. 14. Mery L, Mesaeli N, Michalak M, Opas M, Lew DP, Krause KH: Overexpression of calreticulin increases intracellular Ca2+ storage and decreases store-operated Ca2+ influx. J Biol Chem 1996, 271:9332–9339.PubMedCrossRef 15. Arosa FA, de Jesus O, Porto G, Carmo AM, de Sousa M: Calreticulin is expressed on the cell surface of activated human peripheral blood T lymphocytes in association with major histocompatibility complex class I molecules. J Biol Chem 1999, 274:16917–16922.PubMedCrossRef 16.